An intranasal COVID-19 vaccine elicits long-lasting immunity against SARS-CoV-2 variants in vivo by rss feed | May 11, 2021 | News Feeds A team of scientists from the Washington University School of Medicine and the University of Texas Medical Branch, USA, has recently evaluated the durability and robustness of an adenovirus-vectored, spike-based intranasal COVID-19 vaccine in mice. Read Original Copy